Commercial Operations

Horizon Acquires U.S. Rights to Vimovo

Illinois-based drugmaker Horizon Pharma has acquired the U.S. rights to AstraZeneca’s Vimovo delayed-release tablets in order to bolster the company’s primary care portfolio. Rights outside the U.S. will be retained by AstraZeneca. Read More